The project on the development of new sensitive biomarks for early diagnosis and a better classification of neuroendocrine tumours is well established and running accord to plan. The first patients with NETs have been included in a unique clinical trial with an Oncolytic virus that is only killing the tumour cells and respect normal cells. The results so far look very promising. We expect to get specimens from 35 patients.
Work Placement Inclusion 2013
In May 2012 Invest for children and Aura Foundation signed a collaboration together where Invest for children was named non executive assessor of Aura Foundation. The main objective is that…
see project 
